ReviewAJPM focus2026
HIV Pre-Exposure Prophylaxis Care Continuum in Outpatient Settings: A Systematic Review and Meta-Analysis.
Review in AJPM focus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Introduction: Pre-exposure prophylaxis is a prescription medication that prevents HIV infection and transmission in those at risk for HIV infection. The authors examined engagement in the oral pre-exposure prophylaxis care continuum among HIV-negative individuals at risk for HIV in outpatient settings in the U.S. after participation in a pre-exposure prophylaxis-related intervention, to identify key gaps in the continuum where current interventions are least effective. Methods: This systematic review and meta-analysis included U.S. studies published from January 2012 through August 2022, reporting at least 2 of 7 pre-exposure prophylaxis care continuum steps from the identification of HIV-negative, at-risk pre-exposure prophylaxis-eligible persons to pre-exposure prophylaxis initiation. The final 2 steps-pre-exposure prophylaxis adherence and retention-of the continuum's 9 steps were not analyzed owing to the substantial heterogeneity in how the included studies measured these steps and the limited sample sizes across the studies. Random-effects meta-analyses, which describe the distribution of effects across studies, were performed to estimate pooled proportions of each step, and subgroup analyses were conducted on the basis of population characteristics (e.g., individuals with a sexually transmitted infection, men who have sex with men) and study settings (i.e., emergency department, ambulatory care, healthcare system, and other). Results: The authors included 2,510 articles in title and abstract review, 296 were retrieved for full-text review, and 34 studies met the inclusion criteria and were included in the meta-analysis. The 34 studies were comprised of 71,162 individuals eligible for pre-exposure prophylaxis. Among them, 66% had increased HIV risk awareness, 55% had enhanced pre-exposure prophylaxis awareness, 49% had facilitated pre-exposure prophylaxis access, 42% were linked to pre-exposure prophylaxis care, 40% were prescribed pre-exposure prophylaxis, and 34% initiated pre-exposure prophylaxis use. Subgroup analysis indicated that individuals identified in emergency department settings and those with sexually transmitted infections had lower pre-exposure prophylaxis initiation rates than those identified in all other settings and men who have sex with men, respectively. Discussion: There was a progressive decline in the proportion of individuals engaged in the pre-exposure prophylaxis care continuum. These findings suggest that comprehensive efforts are needed across all settings to increase perceived susceptibility to HIV among high-risk individuals and to capitalize on the opportunity of sexually transmitted infections care and emergency department visits to engage patients in the pre-exposure prophylaxis care continuum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.